TGFB1 and COVID-19: Whereas AXL, which is important for neutrophil infiltration and COVID-19 therapy via regulating TGF-β and PI3K signaling pathways (36, 37), also works as a candidate receptor for SARS-CoV-2 entry (38), was significantly reduced about 3-fold in infected CMs as compared with the healthy control.